F-D-C Reports, Inc. announces the launch of PharmAsiaNews.com: a new subscription-based online service covering Rx drugs, biologics and devices in China, India, Japan and other nations in the Pacific Rim.
ROCKVILLE, Md. (Business Wire EON) January 14, 2008 --
F-D-C Reports, Inc. announces the launch of PharmAsiaNews.com:
a new subscription-based online service covering Rx drugs, biologics and
devices in China, India, Japan and other nations in the Pacific Rim.
“By leveraging the editorial excellence of ‘The
Pink Sheet,’ the leading information source
for U.S. pharmaceutical industry information since 1939 into the Asian
markets and combining it with new features enabled by Web 2.0
technology, we believe PharmAsiaNews.com will become an
important information service to multinational pharmaceutical companies
who are making increasingly larger bets in the region,”
said Gerry Stoia, V.P. of Elsevier Health Science Division’s
Pharma Solutions unit and President of F-D-C Reports, Inc.
“Increasingly over the past several years,
customers have requested reliable, independent and accurate ‘Pink
Sheet like’ coverage of business and
regulatory developments in the APAC region. F-D-C Reports, Inc. has
answered the call for information on developments in China, India, Japan
and other countries in the region via our PharmAsiaNews.com service,”
Stoia added.
The result is a publication that provides readers with the broadest
spectrum of news sources, including: original on-the-ground reporting
from news bureaus across Asia; guest columns; exclusive interviews; news
summaries; English translation summaries of Chinese- and
Japanese-language news; and aggregated content from around the globe.
“What makes PharmAsiaNews.com
unique is our commitment to original local market coverage and insights
developed by local staff who are resident in the market. This is not a
service that provides solely rewritten press releases and translated
local language stories. By leveraging Elsevier’s
global footprint, we’ve brought local talent
aboard to provide our customers with the ‘boots
on the ground’ coverage our customers have
requested,” said Joe Hecker, Editor-in-Chief
at Elsevier’s F-D-C Reports, Inc.
Subscribers to PharmAsiaNews.com get online access to around-the-clock
coverage of the rapidly expanding Asia marketplace, including China,
India, Japan and other nations in the Pacific Rim; twice-weekly email
updates; full archive access; breaking news alerts; and other online
resources.
For more information please visit www.pharmasianews.com
or contact Sean Smith at se.smith@elsevier.com
or call 1-240-221-4535.
About F-D-C Reports
F-D-C Reports, Inc. provides up-to-date information about the worldwide
health care industry via its publications including The Pink Sheet®,
The Gray Sheet®, The Rose Sheet®,
The Tan Sheet®, and Pharmaceutical Approvals
Monthly. The publications are read extensively by pharmaceutical and
healthcare executives, policy-makers, and analysts seeking to understand
the developments affecting the U.S. regulation and marketing of
healthcare products and services. F-D-C Reports, Inc. has one of the
largest, most experienced, and most respected editorial teams reporting
on the latest regulatory, legislative, and business news affecting the
U.S. drug, biotechnology, medical device, nonprescription drug,
nutritionals, and cosmetics industries. F-D-C Reports, Inc. is part of
Elsevier.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
the global science and health communities, Elsevier’s
7,000 employees in over 70 offices worldwide publish more than 2,000
journals and 1,900 new books per year, in addition to offering a suite
of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/),
MD Consult (http://www.mdconsult.com/),
Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/)
is a global business headquartered in Amsterdam, The Netherlands and has
offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/),
a world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business sectors,
Reed Elsevier provides high-quality and flexible information solutions
to users, with increasing emphasis on the Internet as a means of
delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Trackback URL: http://www.prweb.com/pingpr.php/UGlnZy1Qcm9mLVNpbmctVGhpci1Mb3ZlLVplcm8=
|
